Telix Pharmaceuticals Limited TLX
11.45
0.14
1.24%
as of 25 Sep
- Market cap
- $3.9B
- P/E
- —
Follow TLX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | — | — |
+2 more TTM periods Free account |
|
| 0.00% | 0.00% | — | — | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | — | |
Free Cash Flow |
(4.39) | 9.72 | 62.14 | — | |
Capital Expenditures |
(56.26) | (44.90) | (25.64) | — | |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
3.94% | 5.36% | 8.45% | 0.00% | |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | — | — | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | — | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | — | |
Capex per Share |
0.00 | 0.00 | 0.00 | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates